Centogene

Centogene AG is a prominent laboratory specializing in genetic and biochemical diagnostic testing for rare hereditary disorders, catering to the medical community in Germany and globally. The company assists clinicians through genetic counseling, newborn screening, and analysis of biomarkers for lysosomal storage disorders. Centogene has developed a comprehensive rare disease platform that integrates epidemiologic, phenotypic, and genetic data, supported by a biobank of blood samples. It offers a range of services to pharmaceutical partners, including early patient recruitment, epidemiological insights, biomarker discovery, and patient monitoring. Additionally, Centogene provides genetic sequencing and diagnostic services accessible through physicians, laboratories, and hospitals, and offers EXTAN kits for various genetic disorders. Founded in 2006 and headquartered in Rostock, Germany, the company has operations in Berlin, Cambridge, and other locations worldwide. Centogene is recognized as a leader in genetic diagnostics for rare diseases and is committed to transforming genetic data into actionable medical solutions.